HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Andrew Blauvelt Selected Research
Andrew Blauvelt Research Topics
Disease
123
Psoriasis (Pustulosis Palmaris et Plantaris)
03/2024 - 10/2002
51
Atopic Dermatitis (Atopic Eczema)
05/2024 - 02/2003
21
Infections
03/2024 - 03/2002
17
Eczema
05/2024 - 12/2016
17
Inflammation (Inflammations)
04/2024 - 10/2002
14
Neoplasms (Cancer)
03/2024 - 04/2003
9
Skin Diseases (Skin Disease)
12/2023 - 10/2009
9
Pruritus (Itching)
10/2023 - 12/2016
9
Conjunctivitis
03/2023 - 12/2016
7
Injection Site Reaction
09/2021 - 12/2016
6
Psoriatic Arthritis
02/2024 - 08/2015
6
HIV Infections (HIV Infection)
01/2013 - 08/2002
5
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023 - 07/2016
5
Oral Candidiasis (Thrush)
01/2023 - 01/2021
5
Body Weight (Weight, Body)
01/2023 - 01/2017
4
Nasopharyngitis
01/2023 - 01/2016
4
Respiratory Tract Infections (Respiratory Tract Infection)
01/2023 - 10/2020
4
Candidiasis (Moniliasis)
10/2016 - 11/2010
3
Erythema
05/2024 - 03/2019
3
Tuberculosis (Tuberculoses)
10/2023 - 01/2023
3
Skin Neoplasms (Skin Cancer)
01/2023 - 10/2016
3
Pain (Aches)
11/2021 - 01/2017
3
Rheumatoid Arthritis
03/2021 - 01/2017
3
Communicable Diseases (Infectious Diseases)
01/2021 - 03/2004
3
Asthma (Bronchial Asthma)
01/2021 - 10/2017
2
Edema (Dropsy)
05/2024 - 03/2012
2
Acne Vulgaris
03/2024 - 01/2021
2
Herpes Zoster
03/2024 - 09/2021
2
Axial Spondyloarthritis
02/2024 - 01/2019
2
Headache (Headaches)
01/2023 - 01/2021
2
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 11/2021
2
COVID-19
11/2022 - 01/2021
2
Crohn Disease (Crohn's Disease)
02/2020 - 01/2019
2
Hepatitis B
10/2016 - 01/2012
2
Soft Tissue Infections
08/2013 - 05/2010
2
Contact Dermatitis (Eczema, Contact)
03/2012 - 09/2011
2
Hyperplasia
02/2011 - 11/2010
1
Atherosclerosis
04/2024
1
Folliculitis (Sycosis)
03/2024
1
Ankylosing Spondylitis
02/2024
1
Non-Radiographic Axial Spondyloarthritis
02/2024
1
Seborrheic Dermatitis
01/2024
Drug/Important Bio-Agent (IBA)
29
ixekizumab
IBA
03/2024 - 12/2014
28
Interleukin-17 (Interleukin 17)
IBA
03/2024 - 12/2007
27
Monoclonal Antibodies
IBA
04/2024 - 10/2009
26
secukinumab
IBA
03/2024 - 08/2015
25
Immunoglobulin A (IgA)
IBA
05/2024 - 10/2016
23
dupilumab
IBA
02/2024 - 01/2016
22
Cytokines
IBA
12/2023 - 10/2002
20
Interleukins
IBA
04/2024 - 09/2009
15
guselkumab
IBA
02/2024 - 03/2017
14
Interleukin-23 (Interleukin 23)
IBA
12/2023 - 12/2007
14
Etanercept (Enbrel)
FDA Link
01/2022 - 06/2006
13
Adalimumab (Humira)
FDA Link
11/2023 - 05/2011
12
Ustekinumab (CNTO 1275)
FDA Link
01/2023 - 01/2012
11
bimekizumab
IBA
03/2024 - 08/2018
8
Adrenal Cortex Hormones (Corticosteroids)
IBA
12/2023 - 03/2002
7
tralokinumab
IBA
04/2024 - 10/2022
7
Interleukin-13
IBA
04/2024 - 01/2016
7
deucravacitinib
IBA
03/2024 - 01/2022
7
TYK2 Kinase (Tyrosine Kinase 2)
IBA
03/2024 - 01/2021
7
risankizumab
IBA
12/2023 - 01/2017
6
apremilast
IBA
03/2024 - 12/2022
5
lebrikizumab
IBA
05/2024 - 01/2020
5
upadacitinib
IBA
02/2024 - 01/2021
5
Prostaglandins A
IBA
12/2023 - 10/2012
5
Interleukin-12 (IL 12)
IBA
10/2023 - 10/2009
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
08/2018 - 10/2012
4
ruxolitinib
IBA
05/2024 - 01/2023
4
Biomarkers (Surrogate Marker)
IBA
04/2024 - 01/2020
4
Infliximab (Remicade)
FDA Link
11/2023 - 05/2010
4
abrocitinib
IBA
01/2023 - 01/2022
4
omega-Chloroacetophenone (Mace)
IBA
06/2022 - 01/2019
4
Cyclins
IBA
01/2022 - 06/2003
4
brodalumab
IBA
05/2020 - 01/2017
4
Interleukin-4 (Interleukin 4)
IBA
01/2019 - 01/2016
4
Immunoglobulin G (IgG)
IBA
01/2018 - 01/2008
4
Interleukin-22 (IL-22)
IBA
02/2011 - 12/2007
3
Phosphodiesterase 4 Inhibitors
IBA
12/2023 - 12/2022
3
tildrakizumab
IBA
10/2023 - 01/2017
3
Interleukin-23 Subunit p19
IBA
01/2023 - 10/2009
3
Antigens
IBA
01/2022 - 03/2004
3
Tumor Necrosis Factor Inhibitors
IBA
01/2021 - 01/2012
3
Vaccines
IBA
01/2019 - 12/2005
3
Certolizumab Pegol
FDA Link
01/2019 - 08/2018
3
Methotrexate (Mexate)
FDA Link
Generic
10/2016 - 06/2006
3
DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)
IBA
03/2008 - 08/2002
2
Janus Kinases
IBA
01/2022 - 01/2021
2
Janus Kinase Inhibitors
IBA
01/2022 - 01/2021
2
Antibodies
IBA
01/2019 - 10/2018
2
Interleukin-4 Receptors (Interleukin 4 Receptor)
IBA
01/2019 - 12/2016
2
Interleukin-17 Receptors
IBA
12/2018 - 01/2018
2
Interleukin-10 (Interleukin 10)
IBA
07/2015 - 10/2002
2
efalizumab (Raptiva)
FDA Link
05/2008 - 02/2007
2
DNA (Deoxyribonucleic Acid)
IBA
01/2008 - 10/2002
2
C-Type Lectins (C-Type Lectin)
IBA
12/2005 - 03/2004
1
Roflumilast
IBA
01/2024
Therapy/Procedure
33
Therapeutics
03/2024 - 05/2008
5
Biological Therapy
10/2021 - 08/2013
2
Critical Care (Surgical Intensive Care)
01/2021 - 12/2020